[A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
A 62-year-old man with carcinomatous ascites more than 5 years after early gastric cancer operation was admitted to our hospital because of suspected pancreatic cancer, and was diagnosed with a relapse of the gastric cancer. TS-1 was administered at a dose of 120 mg/day. At the end of 1 course a partial response of a decrease of tumor markers and ascites and improvement of QOL was achieved, and the patient was followed in the outpatient clinic. The current case suggests that TS-1 may have a potent therapeutic efficacy in cases of gastric cancer relapse with carcinomatous ascites.
Hatanaka
Fumika
F
Dept. of Gastroenterology, National Kyushu Cancer Center.
Matsuo
Susumu
S
Aratake
Yoshifusa
Y
Uchimura
Koutaro
K
Yokota
Masaki
M
Sumii
Toshihiko
T
Iguchi
Haruo
H
Funakoshi
Akihiro
A
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy / Q000209:etiology; D004334:Drug Administration Schedule; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010094:Oxonic Acid / Q000627:therapeutic use*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D011725:Pyridines / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*; D005641:Tegafur / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D011725:Pyridines; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid